MiR-204 plays key roles in colorectal cancer development and progression, by repressing colorectal cancer cell growth as well as by promoting colorectal cancer cell sensitivity to a chemotherapeutic drug (5-Fu) through directly targeting HMGA2. This evidence concerns the gene HMGA2 and colorectal cancer.